Moderna
MRNA
MRNA
956 hedge funds and large institutions have $30.2B invested in Moderna in 2023 Q2 according to their latest regulatory filings, with 77 funds opening new positions, 307 increasing their positions, 375 reducing their positions, and 120 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
956
Holders Change
-50
Holders Change %
-4.97%
% of All Funds
15.08%
Holding in Top 10
14
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-22.22%
% of All Funds
0.22%
New
77
Increased
307
Reduced
375
Closed
120
Calls
$1.31B
Puts
$1.46B
Net Calls
-$144M
Net Calls Change
-$505M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$707M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
$624M |
| 3 |
Two Sigma Investments
New York
|
$78.3M |
| 4 |
JPMorgan Chase & Co
New York
|
$293M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$542M |
Top Sellers
| 1 |
OIAM
OFI Invest Asset Management
Paris,
France
|
$16.3M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
$20.5M |
| 3 |
BlackRock
New York
|
$2.94B |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$5.55B |
| 5 |
Jane Street
New York
|
$38M |
